Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA

Completed · Phase 4

Conditions studied: Spondylitis, Ankylosing

In brief

The purpose of this study is to study the benefits and risks of etanercept withdrawal in patients who have achieved a significant clinical response.

Key facts

Study ID
NCT02509026
Run by
Pfizer
People needed
210
Starts
2015-09-24
Expected to finish
2019-09-06
Last updated by the study team
2020-06-16

Who can join

Age: 18 and older, up to 49. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.